PharmaNet Development Group’s subsidiary, PharmaNet Canada, Inc. and Maisonneuve-Rosemont Hospital (HMR) and its Research Center, have agreed to collaborate in the conduct of pharmacokinetic studies in patients with impaired renal function. PharmaNet’s clinical pharmacology unit in Canada evaluates new drugs in Phase I studies for its clients. Under the current FDA draft guidance, certain studies require the evaluation of drug products in study participants that have impaired renal func...